Integra LifeSciences slides after lowering annual forecasts

Integra LifeSciences Holdings

02/10/2026 15:10

** Integra LifeSciences IART.O shares fall 14.6% to $13.74 — lowest since May 11 
** The medical equipment maker lowers FY26 revenue outlook to $1.63 bln-$1.65 bln from prior view $1.65 bln-$1.70 bln 
** Cuts FY adj. EPS forecast to $2.30-$2.40 from $2.40-$2.50
** Trims Q3 revenue forecast to $410 mln-$412 mln from $410 mln-$425 mln 
** Says July flooding at Cincinnati facility hurt Q3 revenue by ~$7 mln; sees $15 mln-$20 mln impact on Q4 revenue 
** Expects full manufacturing to resume in Q227
** Three of 12 brokerages rate the stock "buy" or higher, seven "hold" and two "sell" or lower; median PT $19 - LSEG-compiled data
** Including session's move, stock up 10.4% YTD

 (Reporting by Anand Gopal in Bengaluru)
 ((AnandGopal.R@thomsonreuters.com))